Clinical Trials Directory

Trials / Unknown

UnknownNCT05239364

Ablation of Consecutive Atrial Tachycardia

Ablation of CONseCutive atriaL Tachycardia gUided by Ultra-high-DEnsity Mapping

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Evangelical Hospital Düsseldorf · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Ablation of consecutive atrial tachycardia (AT) after ablation of atrial fibrillation (AF) or cardiac surgery can be challenging due to complex substrate and AT mechanisms. A substantial portion of patients is known to show various tachycardias and recurrences occur in a noticeable number of cases. With the availability of novel ultra-high-density mapping techniques characterization and understanding of AT mechanisms and underlying substrate can be improved. Aim of this prospective, multi-center, randomized study is to compare a standard AT ablation approach versus minimalized ablation of the clinical AT in regards to arrhythmia free survival.

Conditions

Interventions

TypeNameDescription
PROCEDURECatheter ablationCatheter-based ablation of arrhythmias using radiofrequency.

Timeline

Start date
2020-12-22
Primary completion
2023-12-01
Completion
2024-12-01
First posted
2022-02-14
Last updated
2022-11-10

Locations

4 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT05239364. Inclusion in this directory is not an endorsement.